Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NURE-Combo: Neoadjuvant Nivolumab + Nab-paclitaxel in MIBC
NCT04876313Phase 2Unknown
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jan 2022
- Primary completion
- Dec 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in muscle-invasive bladder cancer (MIBC), sponsored by IRCCS Ospedale San Raffaele. Status: unknown.
02
Drugs
03
Conditions
muscle-invasive bladder cancer (MIBC)
Beyond the preview
Go deeper on NCT04876313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04876313.